Home / Companies / News / Insiders at covid-19 vaccine makers sold nearly $500 million of stock last year

Insiders at covid-19 vaccine makers sold nearly $500 million of stock last year

An air force medical staff prepares a dose of Moderna COVID-19 vaccine at the vaccination mega center in Athens, Monday, Feb. 15, 2021. The Promitheas center, which has started operating Monday, will host 96 vaccination points and when fully developed, an estimated of 150,000 vaccinations per month could be conducted. (AP Photo/Thanassis Stavrakis) (AP) — An air force medical staff prepares a dose of Moderna COVID-19 vaccine at the vaccination mega center in Athens, Monday, Feb. 15, 2021. The Promitheas center, which has started operating Monday, will host 96 vaccination points and when fully developed, an estimated of 150,000 vaccinations per month could be conducted. (AP Photo/Thanassis Stavrakis) **(AP)**

6 min read . Updated: 18 Feb 2021, 02:18 PM IST Inti Pacheco, The Wall Street Journal

Executives at Moderna, Merck are among those who have reaped the biggest rewards

Executives and directors at Pfizer Inc., Moderna Inc. and other companies developing Covid-19 vaccines sold approximately $496 million of stock last year, reaping rewards of positive vaccine developments that drove up the value of the drugmakers’ shares.